홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Cesium carbonate → 4-(5-cyano-2-methoxyphenyl)-N-(thiazol-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-sulfonamide

HRID 528619
인쇄

반응식

HRID 528619 반응식
COC1C=CC(C[N:8]([C:22]2[S:23][CH:24]=[CH:25][N:26]=2)[S:9]([C:12]2[CH:13]=[CH:14][C:15]3[NH:20][CH2:19][CH2:18][O:17][C:16]=3[CH:21]=2)(=[O:11])=[O:10])=CC=1.Br[C:30]1[CH:31]=[C:32]([CH:35]=[CH:36][C:37]=1[O:38][CH3:39])[C:33]#[N:34].CC1(C)C2C(=C(P(C3C=CC=CC=3)C3C=CC=CC=3)C=CC=2)OC2C(P(C3C=CC=CC=3)C3C=CC=CC=3)=CC=CC1=2.C(=O)([O-])[O-].[Cs+].[Cs+]>C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[C:33]([C:32]1[CH:31]=[CH:30][C:37]([O:38][CH3:39])=[C:36]([N:20]2[CH2:19][CH2:18][O:17][C:16]3[CH:21]=[C:12]([S:9]([NH:8][C:22]4[S:23][CH:24]=[CH:25][N:26]=4)(=[O:10])=[O:11])[CH:13]=[CH:14][C:15]2=3)[CH:35]=1)#[N:34]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 10796Cesium carbonateHCID 6360441,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 7360493-Bromo-4-methoxybenzonitrileHCID 89761436N-(4-methoxybenzyl)-N-(thiazol-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-sulfonamide2회

생성물 1

HCID 897619974-(5-cyano-2-methoxyphenyl)-N-(thiazol-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-sulfonamide
수율 70.6%

시약·촉매·용매 1

HCID 9811564Bis(dibenzylideneacetone)palladium촉매

실험 절차

A vial was charged with N-(4-methoxybenzyl)-N-(thiazol-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-sulfonamide (INTERMEDIate M) (80 mg, 0.192 mmol), 3-bromo-4-methoxybenzonitrile (81 mg, 0.383 mmol), Xantphos (22.17 mg, 0.038 mmol), Pd2(dba)3 (17.55 mg, 0.019 mmol), and cesium carbonate (187 mg, 0.575 mmol). The vessel was flushed with Ar (g), then 1,4-dioxane (1916 μl) was added. The vessel was sealed and placed in a 100° C. heating bath for 20 h. The mixture was filtered through celite with the aid of EtOAc. The filtrate was concentrated, and the residue was dissolved in DCM (1 mL) and TFA (0.5 mL). After 4 h, mixture was diluted with MeOH, then concentrated. The residue was purified by chromatography on silica gel (12-g Redi-Sep Gold column, 0-5% MeOH/DCM). The material this obtained was further purified by chromatography on silica gel (12-g Redi-Sep Gold column, 50-100% EtOAc/Heptane). The resulting solid was taken up in EtOAc, sonicated, and filtered. The collected solid was washed with EtOAc (2×), dried under a stream of N2 (g), then dried under vacuum to give 4-(5-cyano-2-methoxyphenyl)-N-(thiazol-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-sulfonamide (58 mg, 0.135 mmol, 70.6% yield) as an off-white solid: 1H NMR (400 MHz, DMSO-d6) δ=12.55 (br. s., 1 H), 7.92-7.77 (m, 2 H), 7.34 (d, J=8.5 Hz, 1 H), 7.22 (d, J=4.5 Hz, 1 H), 7.16-7.06 (m, 2 H), 6.78 (d, J=4.5 Hz, 1 H), 6.21 (d, J=8.4 Hz, 1 H), 4.30 (br. s., 2 H), 3.85 (s, 3 H), 3.63 (br. s., 2 H); m/z (ESI) 429.2 (M+H)+.

후처리

  1. customThe vessel was flushed with Ar (g)
  2. addition1,4-dioxane (1916 μl) was added
  3. customThe vessel was sealed
  4. customplaced in a 100° C.
  5. temperatureheating bath for 20 h
  6. filtrationThe mixture was filtered through celite with the aid of EtOAc
  7. concentrationThe filtrate was concentrated
  8. dissolutionthe residue was dissolved in DCM (1 mL)
  9. additionmixture was diluted with MeOH
  10. concentrationconcentrated
  11. customThe residue was purified by chromatography on silica gel (12-g Redi-Sep Gold column, 0-5% MeOH/DCM)
  12. customThe material this obtained was further purified by chromatography on silica gel (12-g Redi-Sep Gold column, 50-100% EtOAc/Heptane)
  13. customsonicated
  14. filtrationfiltered
  15. washThe collected solid was washed with EtOAc (2×)
  16. dry with materialdried under a stream of N2 (g)
  17. customdried under vacuum

출처 및 근거

ORD 기록
ord-53ffb7d7e98443368aed2bd8b4ff979d
출처 데이터셋
uspto-grants-2016_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09346798B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트